JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pawlowski, J.
Right arrow Articles by Tonino, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pawlowski, J.
Right arrow Articles by Tonino, P.
Anesth Analg 2000;91:580-584
© 2000 International Anesthesia Research Society


AMBULATORY ANESTHESIA

The Anesthetic and Recovery Profile of Two Doses (60 and 80 mg) of Plain Mepivacaine for Ambulatory Spinal Anesthesia

Julius Pawlowski, MD*, Radha Sukhani, MD*, Ana L. Pappas, MD*, Ku-Mie Kim, MD*, Jordan Lurie, MD*, Helena Gunnerson, MD*, Andrea Corsino, RN, BSN*, Kere Frey, DO*, and Pietro Tonino, MD{dagger}

Departments of *Anesthesiology and {dagger}Orthopedics, Loyola University Medical Center, Maywood, Illinois

Address correspondence to Julius Pawlowski, MD, Department of Anesthesiology, Loyola University Medical Center, 2150 S. First Ave., Maywood, IL 60153.

Reports of transient neurological symptoms with the use of subarachnoid lidocaine has generated interest in alternate local anesthetics of intermediate duration, such as mepivacaine. This prospective randomized, double-blinded, dose-response study examined the anesthetic and recovery profiles of 60- and 80-mg doses of preservative-free plain mepivacaine for ambulatory spinal anesthesia. Sixty patients undergoing ambulatory anterior cruciate ligament repair of the knee under spinal anesthesia were randomized into two groups; Group 1 (29 patients) received 4 mL of 1.5% (60-mg dose) and Group 2 (31 patients) received 4 mL of 2% (80-mg dose) of plain mepivacaine. All patients received a combined spinal-epidural anesthetic technique. The epidural catheter was used only in the event the surgery outlasted the duration of surgical anesthesia with subarachnoid mepivacaine. Epidural supplementation was administered in three patients (12%) in Group 1 and one patient (3%) in Group 2 when the sensory block regressed to L-1 with surgery expected to last longer than 15 min. The cephalad dermatome level of the block and degree of motor block was comparable in the two groups. Times to two-segment and T-10 regression were comparable in the two groups (112 ± 26 min in Group 1 versus 122 ± 28 min in Group 2). Time to L-1 regression was significantly longer in Group 2 (146 ± 28 min in Group 1 versus 159 ± 19 min in Group 2). All of the ambulatory milestones were significantly faster in Group 1. Side effects, such as hypotension and emesis were negligible, severe bradycardia and urinary retention did not occur, and none of the patients in the two groups reported transient neurological symptoms over 24 h. In conclusion, plain mepivacaine in a 60- or 80-mg dose is a suitable local anesthetic choice for ambulatory spinal anesthesia with respect to anesthetic, as well as recovery profiles.

Implications: We evaluated the anesthetic and recovery profiles of 60- and 80-mg doses of plain mepivacaine for ambulatory spinal anesthesia. Both doses produced comparable sensory and motor block. Sensory and motor regression and ambulatory milestones were 20–30 min longer with the 80-mg dose. Side effects were negligible and transient neurological symptoms were not reported during a 24-h follow-up.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
J. T. YaDeau, G. A. Liguori, and V. M. Zayas
The Incidence of Transient Neurologic Symptoms After Spinal Anesthesia with Mepivacaine
Anesth. Analg., September 1, 2005; 101(3): 661 - 665.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
R. W.-L. Goy, Y. Chee-Seng, A. T.-H. Sia, K. Choo-Kok, and S. Liang
The Median Effective Dose of Intrathecal Hyperbaric Bupivacaine Is Larger in the Single-Shot Spinal as Compared with the Combined Spinal-Epidural Technique
Anesth. Analg., May 1, 2005; 100(5): 1499 - 1502.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
N. Rawal
Analgesia for day-case surgery
Br. J. Anaesth., July 1, 2001; 87(1): 73 - 87.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2000 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2000 by the International Anesthesia Research Society.